D(GGGT)4 and r(GGGU)4 are both HIV-1 inhibitors and interleukin-6 receptor aptamers

RNA Biology

Volumn 10, Issue 2, 2013, Pages 216-227

  Magbanua, Eileen ^a   Zivkovic, Tijana ^a   Bjorn Hansen ^a   Beschorner, Niklas ^b   Meyer, Cindy ^a   Lorenzen, Inken ^c   Joachim Grotzinger ^c   Hauber, Joachim ^b   Torda, Andrew E ^a   Gunter Mayer ^d   Rose John, Stefan ^c   Hahn, Ulrich ^a  

^a UNIVERSITY OF HAMBURG   (Germany)

^b LEIBNIZ INSTITUTE FOR EXPERIMENTAL VIROLOGY   (Germany)

^c UNIVERSITY OF KIEL   (Germany)

^d UNIVERSITY OF BONN   (Germany)

Author keywords

Aptamers; G quadruplex; Gp120; HIV; HIV integrase; Interleukin 6 receptor

Indexed keywords

AID 1; AID 1 G10T; AID 1 G14A; AID 1 G14T; AID 1 G1T; AID 1 G2T; AID 1 G3T; AID 1 G6A; AID 1 G6T; AID 1 T; AID 1 T12A; AID 1 T16A; AID 1 T4A; AID 1 T8A; AIR 3A; AIR 3A G17U; AIR 3A G18U; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; APTAMER; INTEGRASE; INTEGRASE INHIBITOR; INTERLEUKIN 6 RECEPTOR; POLYGT; T 30175; T 30923; UNCLASSIFIED DRUG; GLYCOPROTEIN GP 120; GP120 PROTEIN, HUMAN IMMUNODEFICIENCY VIRUS 1; GUANINE QUADRUPLEX; IL6R PROTEIN, HUMAN; OLIGONUCLEOTIDE; T30923;

ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFICACY; DRUG TARGETING; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IN VITRO STUDY; NONHUMAN; CIRCULAR DICHROISM; DRUG EFFECTS; ENZYMOLOGY; GENETICS; HELA CELL LINE; METABOLISM; PATHOGENICITY; PATHOLOGY; PRECLINICAL STUDY; VIROLOGY; VIRUS ATTACHMENT;

APTAMERS, NUCLEOTIDE; CIRCULAR DICHROISM; DRUG EVALUATION, PRECLINICAL; G-QUADRUPLEXES; HELA CELLS; HIV ENVELOPE PROTEIN GP120; HIV INFECTIONS; HIV INTEGRASE; HIV INTEGRASE INHIBITORS; HIV-1; HUMANS; OLIGONUCLEOTIDES; RECEPTORS, INTERLEUKIN-6; VIRUS ATTACHMENT;

EID: 84874631908     PISSN: 15476286     EISSN: 15558584     Source Type: Journal    
DOI: 10.4161/rna.22951     Document Type: Article

References (52)

1. Tuerk C, Gold L. Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science 1990; 249:505-10; PMID:2200121; http://dx.doi.org/10.1126/science. 2200121.
2. Ellington AD, Szostak JW. In vitro selection of RNA molecules that bind specific ligands. Nature 1990; 346:818-22; PMID:1697402; http://dx.doi. org/10.1038/346818a0.
3. Robertson DL, Joyce GF. Selection in vitro of an RNA enzyme that specifically cleaves single-stranded DNA. Nature 1990; 344:467-8; PMID:1690861; http://dx.doi.org/10.1038/344467a0.
4. Holeman LA, Robinson SL, Szostak JW, Wilson C. Isolation and characterization of fluorophorebinding RNA aptamers. Fold Des 1998; 3:423-31; PMID:9889155; http://dx.doi.org/10.1016/S1359-0278(98)00059-5.
5. Blank M, Weinschenk T, Priemer M, Schluesener H. Systematic evolution of a DNA aptamer binding to rat brain tumor microvessels. selective targeting of endothelial regulatory protein pigpen. J Biol Chem 2001; 276:16464-8; PMID:11279054; http://dx.doi. org/10.1074/jbc.M100347200.
6. Lorger M, Engstler M, Homann M, Göringer HU. Targeting the variable surface of African trypanosomes with variant surface glycoprotein-specific, serum-stable RNA aptamers. Eukaryot Cell 2003; 2:84-94; PMID:12582125; http://dx.doi.org/10.1128/EC.2.1.84-94.2003.
7. Gellert M, Lipsett MN, Davies DR. Helix formation by guanylic acid. Proc Natl Acad Sci U S A 1962; 48:2013-8; PMID:13947099; http://dx.doi. org/10.1073/pnas.48.12.2013.
8. Sun H, Bennett RJ, Maizels N. The Saccharomyces cerevisiae Sgs1 helicase efficiently unwinds G-G paired DNAs. Nucleic Acids Res 1999; 27:1978-84; PMID:10198430; http://dx.doi.org/10.1093/nar/27.9.1978.
9. Greider CW, Blackburn EH. Identification of a specific telomere terminal transferase activity in Tetrahymena extracts. Cell 1985; 43:405-13; PMID:3907856; http://dx.doi.org/10.1016/0092-8674(85)90170-9.
10. Blackburn EH. The molecular structure of centromeres and telomeres. Annu Rev Biochem 1984; 53:163-94; PMID:6383193; http://dx.doi.org/10.1146/annurev. bi.53.070184.001115.
11. Kankia BI, Marky LA. Folding of the thrombin aptamer into a G-quadruplex with Sr(2+): stability, heat, and hydration. J Am Chem Soc 2001; 123:10799-804; PMID:11686680; http://dx.doi.org/10.1021/ja010008o.
12. Mashima T, Matsugami A, Nishikawa F, Nishikawa S, Katahira M. Unique quadruplex structure and interaction of an RNA aptamer against bovine prion protein. Nucleic Acids Res 2009; 37:6249-58; PMID:19666719; http://dx.doi.org/ 10.1093/nar/gkp647.
13. Murakami K, Nishikawa F, Noda K, Yokoyama T, Nishikawa S. Anti-bovine prion protein RNA aptamer containing tandem GGA repeat interacts both with recombinant bovine prion protein and its beta isoform with high affinity. Prion 2008; 2:73-80; PMID:19098441; http://dx.doi.org/10.4161/pri.2.2.7024.
14. Mann D, Reinemann C, Stoltenburg R, Strehlitz B. In vitro selection of DNA aptamers binding ethanolamine. Biochem Biophys Res Commun 2005; 338:1928-34; PMID:16289104; http://dx.doi. org/10.1016/j.bbrc.2005.10.172.
15. Meyer C, Eydeler K, Magbanua E, Zivkovic T, Piganeau N, Lorenzen I, et al. Interleukin-6 receptor specific RNA aptamers for cargo delivery into target cells. RNA Biol 2012; 9:67-80; PMID:22258147; http://dx.doi.org/10.4161/rna.9.1. 18062.
16. Soundararajan S, Chen W, Spicer EK, Courtenay-Luck N, Fernandes DJ. The nucleolin targeting aptamer AS1411 destabilizes Bcl-2 messenger RNA in human breast cancer cells. Cancer Res 2008; 68:2358-65; PMID:18381443; http://dx.doi.org/10.1158/0008-5472.CAN-07-5723.
17. Ojwang JO, Buckheit RW, Pommier Y, Mazumder A, De Vreese K, Esté JA, et al. T30177, an oligonucleotide stabilized by an intramolecular guanosine octet, is a potent inhibitor of laboratory strains and clinical isolates of human immunodeficiency virus type 1. Antimicrob Agents Chemother 1995; 39:2426-35; PMID:8585721; http://dx.doi.org/10.1128/AAC.39.11.2426.
18. Li MH, Zhou YH, Luo Q, Li ZS. The 3D structures of G-quadruplexes of HIV-1 integrase inhibitors: molecular dynamics simulations in aqueous solution and in the gas phase. J Mol Model 2010; 16:645-57; PMID:19802725; http://dx.doi.org/10.1007/s00894-009-0592-0.
19. Ojwang J, Elbaggari A, Marshall HB, Jayaraman K, McGrath MS, Rando RF. Inhibition of human immunodeficiency virus type 1 activity in vitro by oligonucleotides composed entirely of guanosine and thymidine. J Acquir Immune Defic Syndr 1994; 7:560-70; PMID:7513761.
20. Jing N, Marchand C, Liu J, Mitra R, Hogan ME, Pommier Y. Mechanism of inhibition of HIV-1 integrase by G-tetrad-forming oligonucleotides in Vitro. J Biol Chem 2000; 275:21460-7; PMID:10801812; http://dx.doi.org/10.1074/jbc. M001436200.
21. Kelley S, Boroda S, Musier-Forsyth K, Kankia BI. HIV-integrase aptamer folds into a parallel quadruplex: a thermodynamic study. Biophys Chem 2011; 155:82-8; PMID:21435774; http://dx.doi.org/10.1016/j. bpc.2011.03.004.
22. Jing N, Hogan ME. Structure-activity of tetrad-forming oligonucleotides as a potent anti-HIV therapeutic drug. J Biol Chem 1998; 273:34992-9; PMID:9857031; http://dx.doi.org/10.1074/jbc.273.52.34992.
23. Esté JA, Cabrera C, Schols D, Cherepanov P, Gutierrez A, Witvrouw M, et al. Human immunodeficiency virus glycoprotein gp120 as the primary target for the antiviral action of AR177 (Zintevir). Mol Pharmacol 1998; 53:340-5; PMID:9463493.
24. Jones SA, Scheller J, Rose-John S. Therapeutic strategies for the clinical blockade of IL-6/gp130 signaling. J Clin Invest 2011; 121:3375-83; PMID:21881215; http://dx.doi.org/10.1172/JCI57158.
25. Stahl SJ, Zinn K. Nucleotide sequence of the cloned gene for bacteriophage T7 RNA polymerase. J Mol Biol 1981; 148:481-5; PMID:7310873; http://dx.doi. org/10.1016/0022-2836(81)90187-X.
26. Jostock T, Müllberg J, Ozbek S, Atreya R, Blinn G, Voltz N, et al. Soluble gp130 is the natural inhibitor of soluble interleukin-6 receptor transsignaling responses. Eur J Biochem 2001; 268:160-7; PMID:11121117; http://dx.doi.org/10.1046/j.1432-1327.2001.01867.x.
27. Fischer M, Goldschmitt J, Peschel C, Brakenhoff JP, Kallen KJ, Wollmer A, et al. I. A bioactive designer cytokine for human hematopoietic progenitor cell expansion. Nat Biotechnol 1997; 15:142-5; PMID:9035138; http://dx.doi.org/10. 1038/nbt0297-142.
28. Mayer G, Wulffen B, Huber C, Brockmann J, Flicke B, Neumann L, et al. An RNA molecule that specifically inhibits G-protein-coupled receptor kinase 2 in vitro. RNA 2008; 14:524-34; PMID:18230760; http://dx.doi.org/10.1261/rna.821908.
29. Müller J, El-Maarri O, Oldenburg J, Pötzsch B, Mayer G. Monitoring the progression of the in vitro selection of nucleic acid aptamers by denaturing high-performance liquid chromatography. Anal Bioanal Chem 2008; 390:1033-7; PMID:17994225; http://dx.doi. org/10.1007/s00216-007-1699-8.
30. Lu M, Guo Q, Kallenbach NR. Thermodynamics of G-tetraplex formation by telomeric DNAs. Biochemistry 1993; 32:598-601; PMID:8422371; http://dx.doi.org/10.1021/bi00053a027.
31. Parissi V, Caumont AB, de Soultrait VR, Calmels C, Pichuantes S, Litvak S, et al. Selection of amino acid substitutions restoring activity of HIV-1 integrase mutated in its catalytic site using the yeast Saccharomyces cerevisiae. J Mol Biol 2000; 295:755-65; PMID:10656788; http://dx.doi.org/10. 1006/jmbi.1999.3416.
32. Mazumder A, Cooney D, Agbaria R, Gupta M, Pommier Y. Inhibition of human immunodeficiency virus type 1 integrase by 3'-azido-3'-deoxythymidylate. Proc Natl Acad Sci U S A 1994; 91:5771-5; PMID:8016063; http://dx.doi.org/10.1073/ pnas.91.13.5771.
33. Wei X, Decker JM, Liu H, Zhang Z, Arani RB, Kilby JM, et al. Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy. Antimicrob Agents Chemother 2002; 46:1896-905; PMID:12019106; http://dx.doi. org/10.1128/AAC.46.6.1896-1905.2002.
34. Pettersen EF, Goddard TD, Huang CC, Couch GS, Greenblatt DM, Meng EC, et al. UCSF Chimera-a visualization system for exploratory research and analysis. J Comput Chem 2004; 25:1605-12; PMID:15264254; http://dx.doi.org/10.1002/jcc. 20084.
35. Zhang W, Hou T, Schafmeister C, Ross WS, Case DA. LEaP and gleap. Amber Tools Users' Manual Version 1.4: AMBER, 2010.
36. Van Der Spoel D, Lindahl E, Hess B, Groenhof G, Mark AE, Berendsen HJC. GROMACS: fast, flexible, and free. J Comput Chem 2005; 26:1701-18; PMID:16211538; http://dx.doi.org/10.1002/jcc.20291.
37. Pérez A, Marchán I, Svozil D, Sponer J, Cheatham TE 3rd, Laughton CA, et al. Refinement of the AMBER force field for nucleic acids: improving the description of alpha/gamma conformers. Biophys J 2007; 92:3817-29; PMID:17351000; http://dx.doi.org/10.1529/biophysj. 106.097782.
38. Margraf T, Schenk G, Torda AE. The SALAMI protein structure search server. Nucleic Acids Res 2009; 37(Web Server issue):W480-4; PMID:19465380; http://dx.doi.org/10.1093/nar/gkp431.
39. Hasegawa H, Holm L. Advances and pitfalls of protein structural alignment. Curr Opin Struct Biol 2009; 19:341-8; PMID:19481444; http://dx.doi. org/10.1016/j.sbi.2009.04.003.
40. Ye Y, Godzik A. FATCAT: a web server for flexible structure comparison and structure similarity searching. Nucleic Acids Res 2004; 32(Web Server issue):W582-5; PMID:15215455; http://dx.doi. org/10.1093/nar/gkh430.
41. Jing N, Rando RF, Pommier Y, Hogan ME. Ion selective folding of loop domains in a potent anti-HIV oligonucleotide. Biochemistry 1997; 36:12498-505; PMID:9376354; http://dx.doi.org/10.1021/bi962798y.
42. Jing N, De Clercq E, Rando RF, Pallansch L, Lackman-Smith C, Lee S, et al. Stability-activity relationships of a family of G-tetrad forming oligonucleotides as potent HIV inhibitors. A basis for anti-HIV drug design. J Biol Chem 2000; 275:3421-30; PMID:10652335; http://dx.doi.org/10.1074/jbc.275.5. 3421.
43. Mazumder A, Neamati N, Ojwang JO, Sunder S, Rando RF, Pommier Y. Inhibition of the human immunodeficiency virus type 1 integrase by guanosine quartet structures. Biochemistry 1996; 35:13762-71; PMID:8901518; http://dx.doi.org/10.1021/bi960541u.
44. Joachimi A, Benz A, Hartig JS. A comparison of DNA and RNA quadruplex structures and stabilities. Bioorg Med Chem 2009; 17:6811-5; PMID:19736017; http://dx.doi.org/10.1016/j.bmc.2009.08.043.
45. Varghese JN, Moritz RL, Lou MZ, Van Donkelaar A, Ji H, Ivancic N, et al. Structure of the extracellular domains of the human interleukin-6 receptor alpha-chain. Proc Natl Acad Sci U S A 2002; 99:15959-64; PMID:12461182; http://dx.doi.org/10.1073/pnas.232432399.
46. Christ F, Voet A, Marchand A, Nicolet S, Desimmie BA, Marchand D, et al. Rational design of smallmolecule inhibitors of the LEDGF/p75-integrase interaction and HIV replication. Nat Chem Biol 2010; 6:442-8; PMID:20473303; http://dx.doi.org/10.1038/nchembio.370.
47. Lauhon CT, Szostak JW. RNA aptamers that bind flavin and nicotinamide redox cofactors. J Am Chem Soc 1995; 117:1246-57; PMID:11539282; http://dx.doi. org/10.1021/ja00109a008.
48. Walsh R, DeRosa MC. Retention of function in the DNA homolog of the RNA dopamine aptamer. Biochem Biophys Res Commun 2009; 388:732-5; PMID:19699181; http://dx.doi.org/10.1016/j. bbrc.2009.08.084.
49. Honda M, Yamamoto S, Cheng M, Yasukawa K, Suzuki H, Saito T, et al. Human soluble IL-6 receptor: its detection and enhanced release by HIV infection. J Immunol 1992; 148:2175-80; PMID:1545125.
50. Novick D, Shulman LM, Chen L, Revel M. Enhancement of interleukin 6 cytostatic effect on human breast carcinoma cells by soluble IL-6 receptor from urine and reversion by monoclonal antibody. Cytokine 1992; 4:6-11; PMID:1617157; http://dx.doi.org/10.1016/1043-4666(92)90029-Q.
51. Zhou J, Rossi JJ. Cell-specific aptamer-mediated targeted drug delivery. Oligonucleotides 2011; 21:1-10; PMID:21182455; http://dx.doi.org/10.1089/oli. 2010.0264.
52. Hazel P, Huppert J, Balasubramanian S, Neidle S. Loop-length-dependent folding of G-quadruplexes. J Am Chem Soc 2004; 126:16405-15; PMID:15600342; http://dx.doi.org/10.1021/ja045154j.